Back to Search Start Over

EUS-derived criteria for distinguishing benign from malignant metastatic solid hepatic masses.

Authors :
Fujii-Lau LL
Abu Dayyeh BK
Bruno MJ
Chang KJ
DeWitt JM
Fockens P
Forcione D
Napoleon B
Palazzo L
Topazian MD
Wiersema MJ
Chak A
Clain JE
Faigel DO
Gleeson FC
Hawes R
Iyer PG
Rajan E
Stevens T
Wallace MB
Wang KK
Levy MJ
Source :
Gastrointestinal endoscopy [Gastrointest Endosc] 2015 May; Vol. 81 (5), pp. 1188-96.e1-7. Date of Electronic Publication: 2015 Feb 07.
Publication Year :
2015

Abstract

Background: Detection of hepatic metastases during EUS is an important component of tumor staging.<br />Objective: To describe our experience with EUS-guided FNA (EUS-FNA) of solid hepatic masses and derive and validate criteria to help distinguish between benign and malignant hepatic masses.<br />Design: Retrospective study, survey.<br />Setting: Single, tertiary-care referral center.<br />Patients: Medical records were reviewed for all patients undergoing EUS-FNA of solid hepatic masses over a 12-year period.<br />Interventions: EUS-FNA of solid hepatic masses.<br />Main Outcome Measurements: Masses were deemed benign or malignant according to predetermined criteria. EUS images from 200 patients were used to create derivation and validation cohorts of 100 cases each, matched by cytopathologic diagnosis. Ten expert endosonographers blindly rated 15 initial endosonographic features of each of the 100 images in the derivation cohort. These data were used to derive an EUS scoring system that was then validated by using the validation cohort by the expert endosonographer with the highest diagnostic accuracy.<br />Results: A total of 332 patients underwent EUS-FNA of a hepatic mass. Interobserver agreement regarding the initial endosonographic features among the expert endosonographers was fair to moderate, with a mean diagnostic accuracy of 73% (standard deviation 5.6). A scoring system incorporating 7 EUS features was developed to distinguish benign from malignant hepatic masses by using the derivation cohort with an area under the receiver operating curve (AUC) of 0.92; when applied to the validation cohort, performance was similar (AUC 0.86). The combined positive predictive value of both cohorts was 88%.<br />Limitations: Single center, retrospective, only one expert endosonographer deriving and validating the EUS criteria.<br />Conclusion: An EUS scoring system was developed that helps distinguish benign from malignant hepatic masses. Further study is required to determine the impact of these EUS criteria among endosonographers of all experience.<br /> (Copyright © 2015 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-6779
Volume :
81
Issue :
5
Database :
MEDLINE
Journal :
Gastrointestinal endoscopy
Publication Type :
Academic Journal
Accession number :
25660980
Full Text :
https://doi.org/10.1016/j.gie.2014.10.035